2-(4-(4-chlorophenoxy)phenyl)-1H-benzimidazole-5-carboxamide,
CHK2iII compound,
BML-277,
516480-79-8,
Chk2 Inhibitor II,
Chk2 Inhibitor II hydrate,
CHEMBL179583,
2-(4-(4-chlorophenoxy)phenyl)-1H-benzimidazole-5-carboxamide,
MFCD08276917,
C20H14ClN3O2,
2-[4-(4-Chlorophenoxy)phenyl]-1h-Benzimidazole-6-Carboxamide,
2-[4-(4-chlorophenoxy)phenyl]-1H-1,3-benzodiazole-6-carboxamide,
2-arylbenzimidazole,
4a9r,
chk2-inhibitor-2-bml-277,
MLS006010751,
BML277,
GTPL5954,
SCHEMBL1723139,
BDBM34064,
CTK8E8283,
DTXSID40433479,
Chk2 Inhibitor II (BML-277),
HMS3229E12,
BCP09077,
EX-A1077,
ZINC3815901,
3495AH,
IN1500,
NSC741899,
AKOS026750319,
CCG-206833,
CS-1809,
NSC-741899,
KS-00001D87,
NCGC00165768-01,
NCGC00165768-02,
NCGC00165768-05,
ACM516480798,
AK205193,
BC600671,
HY-13946,
SMR004701704,
RT-011573,
FT-0700052,
Chk2 Inhibitor II hydrate, >=98% (HPLC),
C 3742,
2-(4-(4-chlorophenoxy)phenyl)-1h-benzimidazole -5-carboxamide,
2-[4-(4-Chlorophenoxy)phenyl]-1H-benzoimidazole-5-carboxamide,
2-(4-(4-chlorophenoxy)phenyl)-1H-benzo[d]imidazole-6-carboxamide,
C-3742|||2-[4-(4-chlorophenoxy)phenyl]-3H-benzimidazole-5-carboxamide,
RU5,
D0EM1C,
CID9969021,
B1236,
A13575,
2-(4-(4-Chlorophenoxy)phenyl)-1H-benzimidazole-5-carboxamide hydrate,
2-[4-(4-chlorophenoxy)phenyl]-3H-benzoimidazole-5-carboxamide,